|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS: CHARACTERIZATION SERIES |
aDepartment of Comparative Medicine and
bDivision of Hematology, Department of Medicine, University of Washington, Seattle, Washington, USA
Key Words. Human embryonic stem cell • Doubling time • Cloning • Transfection
Correspondence: Carol B. Ware, Ph.D., University of Washington, Box 357190, Seattle, Washington 98195, USA. Telephone: 206-616-5143; Fax: 206-685-3006; e-mail: cware{at}u.washington.edu
Received September 16, 2005;
accepted for publication July 27, 2006.
First published online in STEM CELLS EXPRESS August 17, 2006.
In October 2003, the NIH established three extramural "Exploratory Centers for Human Embryonic Stem Cell Research." Our center acquired 15 of the 22 NIH-approved cell lines. Lines were tested for: (a) freedom from mycoplasma contamination; (b) appropriate pattern of gene expression during self-renewal and differentiation; (c) ability to adapt to uniform culture conditions; (d) ability to grow at clonal densities; (e) karyotype; (f) growth efficiency; and (g) efficiency of stable transfection following electroporation. One line harbored mycoplasma. Ten lines were converted to uniform conditions. Nine lines were fully characterized. Human ESC (hESC) lines varied markedly with respect to growth efficiency as measured by the amount of time it took to plate and double (3157 hours), cloning efficiency (0.8%9.2%), and stable transfection rates following electroporation (0%53% relative to a standard mouse ESC line). One hESC line had an unstable karyotype at an early passage. Modifications of the proposed Material Transfer Agreements with hESC suppliers were required to improve accessibility to hESC lines by local researchers. The NIH-approved hESC lines vary in their behavior in culture. Many hESC lines can be maintained using culture conditions less onerous than those recommended by their suppliers. Intellectual property issues pose a significant obstacle to research using NIH-approved hESC lines.
This article has been cited by other articles:
![]() |
M. Bar, S. K. Wyman, B. R. Fritz, J. Qi, K. S. Garg, R. K. Parkin, E. M. Kroh, A. Bendoraite, P. S. Mitchell, A. M. Nelson, et al. MicroRNA Discovery and Profiling in Human Embryonic Stem Cells by Deep Sequencing of Small RNA Libraries Stem Cells, October 1, 2008; 26(10): 2496 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Navara, J. D. Mich-Basso, C. J. Redinger, A. Ben-Yehudah, E. Jacoby, E. Kovkarova-Naumovski, M. Sukhwani, K. Orwig, N. Kaminski, C. A. Castro, et al. Pedigreed Primate Embryonic Stem Cells Express Homogeneous Familial Gene Profiles Stem Cells, November 1, 2007; 25(11): 2695 - 2704. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ilancheran, A. Michalska, G. Peh, E. M Wallace, M. Pera, and U. Manuelpillai Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential Biol Reprod, September 1, 2007; 77(3): 577 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ellerstrom, R. Strehl, K. Noaksson, J. Hyllner, and H. Semb Facilitated Expansion of Human Embryonic Stem Cells by Single-Cell Enzymatic Dissociation Stem Cells, July 1, 2007; 25(7): 1690 - 1696. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
